@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com 5 years ago
Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests
@techcrunch.com 7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons